About IBL International
IBL International is a Healthcare company based in Mannedorf (Switzerland) founded in 1980, and was acquired by Tecan in July 2014. Immunoassays and antibodies are supplied for diagnostic applications in labs. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Drug Discovery.
Company details
Founded in 1980 and based in Mannedorf, Switzerland, IBL International operates in the biotechnology sector, specializing in enzyme, radio, and luminescence immunoassays along with antibodies. These products support routine diagnosis in research, clinical, and specialty laboratories, with emphasis on areas such as endocrinology, neurodegeneration, infectious diseases, and autoimmunity. Distribution occurs online and through a global network.
- Headquarters Mannedorf, Switzerland
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website ibl-international.com
- Social LinkedIn Facebook
- Acquired by Tecan (Jul 2014)
Investors in IBL International
IBL International has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Tecan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Automated laboratory instruments, robotics, and diagnostic solutions are provided. | 1980 | tecan.com | Mannedorf, Switzerland |
Investor details for IBL International
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of IBL International
2 dated milestones of IBL International across 34 years, from founding to its latest funding, stage changes and deals.
- Founded IBL International is founded.
- Exit Acquired by Tecan.
Web traffic of IBL International
The website of IBL International (ibl-international.com) receives about 9.1K visits a month.
- Monthly visits9.1K
▲ 48.4% vs previous month
Websites whose visitors overlap most with IBL International. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| annardx.com | 100% | View details | |||
labnet.health.nz | labnet.health.nz | 96% | – | ||
| novatec-id.com | 95% | View details | |||
leistungsverzeichnis.labor-gaertner.de | leistungsverzeichnis.labor-gaertner.de | 94% | – | ||
| orgentec.com | 93% | 13.9K | #1,936,454 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for IBL International
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IBL International
IBL International was founded in 1980.
IBL International is headquartered in Mannedorf, Switzerland. It is registered at Mannedorf, Zurich, Switzerland.
Founded in 1980 and based in Mannedorf, Switzerland, IBL International operates in the biotechnology sector, specializing in enzyme, radio, and luminescence immunoassays along with antibodies. These products support routine diagnosis in research, clinical, and specialty laboratories, with emphasis on areas such as endocrinology, neurodegeneration, infectious diseases, and autoimmunity. Distribution occurs online and through a global network.
IBL International has 1 investor. Key investors include Tecan.
Yes. IBL International was acquired by Tecan in July 2014.